Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 35

Results For "Disorders"

367 News Found

Air pollution reduces life expectancy by eight years in India
News | November 25, 2021

Air pollution reduces life expectancy by eight years in India

India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution


Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn
Biotech | November 20, 2021

Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn

Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease


CIMS multi super specialty hospital performs 150 bone marrow transplants
Public Health | November 19, 2021

CIMS multi super specialty hospital performs 150 bone marrow transplants

The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017


World’s first Whole Genome Sequencing study uncovers new and potential therapies
News | November 12, 2021

World’s first Whole Genome Sequencing study uncovers new and potential therapies

The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families


LifeCell Diagnostics expands newborn screening portfolio
Clinical Trials | November 11, 2021

LifeCell Diagnostics expands newborn screening portfolio

LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns


U.S. FDA approves ANI’s purified cortrophin gel
Biotech | November 03, 2021

U.S. FDA approves ANI’s purified cortrophin gel

Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016


Apollo Hospitals announces free Covid-19 vaccines to kids with co-morbidities
Hospitals | October 26, 2021

Apollo Hospitals announces free Covid-19 vaccines to kids with co-morbidities

The list of kids with co-morbidities eligible for vaccination would be announced by the government


Zydus announces update on a randomised trial of Saroglitazar Mg in NASH
Biotech | October 22, 2021

Zydus announces update on a randomised trial of Saroglitazar Mg in NASH

Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders


We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare
interviews | October 20, 2021

We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare

Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.


Resilience and Harvard announce five-year R&D alliance
News | October 18, 2021

Resilience and Harvard announce five-year R&D alliance

First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders